Engineering Superior Treatments for Patients with Life-Threatening and Function-Threatening Diseases

About Valitor

Valitor’s technology enables us to engineer BioBetter products with previously unattainable pharmacological properties to maximize clinical impact

Our technology

Our core technology platform originated at UC Berkeley and enables us to generate multivalent protein (MVP) conjugates by tethering multiple copies of bioactive molecules (e.g., camelid antibodies, cytokines, etc.) to single-chain, soluble biopolymers. Using Valitor’s propriety compositions and chemistry methods, our MVPs exhibit the following advantages over other therapeutic products that are either on the market or in development: